CoreCap Advisors’s Hims & Hers Health HIMS Stock Holding History

CoreCap Advisors’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.3K	Sell	245 -85	-26%	-$2.61K	﹤0.01%	2157
2026 Q2	$11.4K	Buy	330 +310	+1,550%	+$8.32K	﹤0.01%	2018
2026 Q1	$415	Hold	20	–	–	﹤0.01%	2682
2025 Q4	$649	Sell	20 -2,447	-99%	-$105K	﹤0.01%	2665
2025 Q3	$140K	Sell	2,467 -7,958	-76%	-$408K	0.01%	914
2025 Q2	$520K	Buy	10,425 +9,925	+1,985%	+$449K	0.02%	505
2025 Q1	$14.8K	Buy	500 +352	+238%	+$13.1K	﹤0.01%	1662
2024 Q4	$3.58K	Sell	148 -42,318	-100%	-$1.05M	﹤0.01%	2058
2024 Q3	$782K	Buy	+42,466	New	+$760K	0.04%	361

Other funds holding HIMS

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Legacy Advisors Plymouth Meeting, Pennsylvania $1.05B AUM 17.6% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

STAS

Strong Tower Advisory Services Minneapolis, Minnesota $568M AUM 13.18% 1-Year Est. Return

WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Winnow Wealth Waco, Texas $151M AUM 17.14% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

CoreCap Advisors's HIMS Position: Q3 2026 in Review

CoreCap Advisors reduced its Hims & Hers Health (HIMS) stake by 26% in Q3 2026, selling an estimated $2.61K and leaving 245 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

CoreCap Advisors first reported a position in HIMS in Q3 2024 and has held it in 9 quarters since. The position peaked at $782K in Q3 2024. 42 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

CoreCap Advisors held 245 shares of Hims & Hers Health worth $7.3K as of Q3 2026.
CoreCap Advisors sold 85 Hims & Hers Health shares in Q3 2026, an estimated $2.61K.
Hims & Hers Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2157 holding.
CoreCap Advisors first reported a position in Hims & Hers Health in Q3 2024 and has held it in 9 quarters since.
CoreCap Advisors's Hims & Hers Health position peaked at $782K in Q3 2024.
42 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.